Summit Therapeutics (NASDAQ:SMMT) has appointed Robert LaCaze as chief commercial officer, reporting to Manmeet S. Soni, chief operating officer and chief financial…
Read More »Therapeutics
Atstock Productions Knight Therapeutics (TSX:GUD:CA) has entered into a definitive asset purchase agreement with Endo Operations and Paladin Pharma, to…
Read More »
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver…
Read More »
New York, New York–(Newsfile Corp. – January 26, 2025) – WHY: Rosen Law Firm, a global investor rights law firm,…
Read More » New York, New York–(Newsfile Corp. – January 18, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces…
Read More »
SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), recently sold a portion of his holdings in the company. According…
Read More » New York, New York–(Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating…
Read More » Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics…
Read More » New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm,…
Read More »